GH1 and neuroendocrine neoplasm: Both central hypothalamic tumours (usually gangliocytomas) and peripheral neuroendocrine tumours could secrete growth hormone–releasing hormone (GHRH), inducing somatotroph proliferation (and very rarely, the formation of an adenoma), with resultant elevations in levels of growth hormone and IGF-I [18].